19 results on '"Jeffrey A. Stafford"'
Search Results
2. Supplementary Figure Legends from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
3. Supplementary Table S4 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
4. Supplementary Table S1 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
5. Supplementary Table S2 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
6. Figure S5 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
7. Supplementary Table S3 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
8. Figure S6 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
9. Figure S3 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
10. Figure S2 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
11. Supplementary Fig. S1 from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
12. Figure S4 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
13. Figure S1 from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
14. Data from Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
15. Data from KDM4 Inhibition Targets Breast Cancer Stem–like Cells
16. Abstract 3720: TACH101, a first-in-class inhibitor of KDM4 histone lysine demethylase for the treatment of diffuse large B-cell lymphoma
17. Abstract P086: Identification of pharmacodynamic and sensitivity biomarkers for TACH101, a pan-inhibitor of KDM4 histone lysine demethylase
18. KDM4 Inhibition Targets Breast Cancer Stem–like Cells
19. Abstract 2128: TACH101, a first-in-class pan inhibitor of KDM4 histone lysine demethylases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.